Catherine J. Frompovich
HPV, the human papillomavirus, is a relatively newer health scare that has been bandied around as causing cervical cancer since 2006-08 in order to get adolescent girls to accept willingly Merck & Company’s HPV vaccine Gardasil® along with its advertising campaign, “One less girl.” 
However, according to the U.S. Centers for Disease Control and Prevention (CDC),
Other things can increase your risk of cervical cancer—
Having HIV (the virus that causes AIDS) or another condition that makes it hard for your body to fight off health problems.
Using birth control pills for a long time (five or more years). [something not stressed]
Having given birth to three or more children.
Having several sexual partners. [1a] [CJF emphasis]
Keeping in mind the “One less girl” campaign, what were the HPV vaccination rates for girls in the United States, especially since the HPV vaccine was supposed to provide protection from cancer?
Original information released about the HPV vaccine contended that it provided protection from contracting cervical cancer, whereas what it really was designed to do was prevent contracting four HPV virus strains. However, there are more than 100 HPV strains. How about 120! 
From 2011 to 2012, vaccination coverage among U.S. adolescents between the ages of 13 and 17 years increased to about 85% for at least one dose of Tdap vaccine, 74% for at least one dose of MCV4 vaccine, and, among males, to about 21% for at least one dose of HPV vaccine. In 2012, vaccination coverage for at least one dose of HPV vaccine among females approached 54%, remaining statistically unchanged since 2011. Only one-third of female teens received all 3 recommended doses of the HPV vaccine series in 2012.  [CJF emphasis added]
With only four strains in the HPV vaccine, how much ‘protection’ does any HPV vaccine provide when, according to Wikipedia,
Types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82 are carcinogenic “high-risk” sexually transmitted HPVs and may lead to the development of cervical intraepithelial neoplasia (CIN), vulvar intraepithelial neoplasia (VIN), penile intraepithelial neoplasia (PIN), and/or anal intraepithelial neoplasia (AIN). 
Wikipedia  lists the following information about HPV types.
GARDASIL is a sterile suspension for intramuscular administration. Each 0.5-mL dose contains approximately 20 mcg of HPV 6 L1 protein, 40 mcg of HPV 11 L1 protein, 40 mcg of HPV 16 L1 protein, and 20 mcg of HPV 18 L1 protein.
Each 0.5-mL dose of the vaccine contains approximately 225 mcg of aluminum (as Amorphous Aluminum Hydroxyphosphate Sulfate adjuvant), 9.56 mg of sodium chloride, 0.78 mg of L-histidine, 50 mcg of polysorbate 80, 35 mcg of sodium borate, less than 7 mcg yeast protein/dose, and water for injection. The product does not contain a preservative or antibiotics.
After thorough agitation, GARDASIL is a white, cloudy liquid.  [CJF emphasis added]
According to the HuffPost Healthy Living Oct. 28, 2013 article “HPV Vaccine May Not Protect Against Subtypes That Most Commonly Affect African American Women,” there seems to be a huge disparity of scientific information about the ability of HPV vaccines to provide the much exalted protection from HPV vaccines, when
Among the women with early CIN [cervical intraepithelial neoplasia], HPV subtypes 16, 18, 31, 56, 39 and 66 were the most frequently detected among white women. For African American women, though, the HPV subtypes 33, 35, 58 and 68 were most frequently detected.
So which strains do Gardasil include? 6, 11, 16, 18—only 2 out of 6 CIN-identified strains for white [Caucasian] women, and apparently none of the 4 most frequently detected CIN-identified strains in African American women.
However, in CIN-2 and CIN-3 reports in African American women, the most commonly found HPV strains were: 31, 35, 45, 56, 58, 66, and 68—all linked to cervical cancer! 
In October of 2009, the FDA granted license to Merck for Gardasil use in males 9 through 26 years of age. 
A new study regarding HPV vaccines was published November 4, 2013 in the journal Cancer Prevention Research. Mahboobeh Safaeian, PhD, says, “For instance, it is important to note that persistence of antibody responses after a single dose has not been evaluated for Gardasil, the quadrivalent HPV vaccine that is more widely used in the United States and many other countries”  with regard to reducing the number of HPV shots from 3 to 2 or even 1.
Dr. Safaeian also says that cervical cancer is a major cause of public health concern in less developed countries where most cervical cancer statistics originate, i.e., 85 percent. Why? Basically, because there is a lack of screening infrastructure, which is excellent in the United States with pap tests/screening, which should not be rejected in lieu of the HPV vaccines and media campaigns. According to Dr. Diane Harper, MD, who worked on clinical trials for both HPV vaccines, “HPV vaccines are an option, not a replacement for Pap testing.” 
It seems that the makers of the HPV vaccines may be looking to backing off the protocol of 3 doses given over a designated time frame. Could it be that there are too many parents and teens refusing them? Or, is word getting out about the health risks and damage that have occurred to girls who received them? Two website are devoted to HPV vaccine damage information. They are:
Could stories like those provided to this writer by SaneVax’s president Norma Erickson be responsible for the rejection of the HPV vaccine along with vaccine makers rethinking some vaccine protocols and strategies?
Norma says, “We have 142 stories of victims on our site – 12 of them are deceased. All of them are heart-breaking.”
- This one just went through cervical cancer treatment and was told – “You don’t want cancer again, do you?” http://sanevax.org/lived-gardasil-nightmare/
- This one was started on Gardasil shortly after the birth of her first child – http://sanevax.org/gardasil-made-one-less-healthy-american-girl/
- This one was 26 and about to be married – doctor administered even though “he didn’t see any point to it.” http://sanevax.org/hpv-vaccine-journey-gardasil-injuries/
- This one was injected at 12 years old – only one shot – now lives with ITP – http://sanevax.org/how-gardasil-changed-my-life/
- This one went from Olympic hopeful to virtually paralyzed – http://sanevax.org/update-on-shania-the-flyer-mandurah-western-australia/ (earlier version is here – http://sanevax.org/shania-from-australia/)
- This one had a previous adverse reaction to MMR – and was administered Cervarix® anyway – http://sanevax.org/post-cervarix-syndrome-lucy-from-the-uk/
- Our Vaccine Victim’s Memorial Video is here – http://sanevax.org/gardasil-victims-memorial-dont-become-one-more-girl/ – at the time it was made, there had only been 89 deaths recorded in VAERS – now, there are 144.
According to a survey taken for the years 2008 to 2010, nationally an average of 28 percent of females started the HPV series, but only 17 percent completed the 3 dose protocol over a course of 3 years.  What is not talked about when supplying HPV vaccine information is the fact that out of all the serious vaccine adverse events reported to the CDC’s Vaccine Adverse Event Reporting System (VAERS), more than half come from HPV vaccines. Furthermore, of the 80 vaccines approved by the FDA, HPV vaccines account for 25 percent of the VAERS database.
As SaneVax’s Norma Erickson says, “This is quite an ‘accomplishment’ since they have been on the market for less than 7 years.”
According to The Washington Times April 10, 2013 article “US court pays $6 million to Gardasil victims,” 26 deaths tragically occurred to perfectly healthy girls in just one year after receiving Gardasil vaccinations!  Furthermore, this very disconcerting information taken from that article really needs to be addressed legally and very soon:
HPV vaccines have been illegally administered to millions without informed consent, as the risks rarely disclosed.
According to Judicial Watch president, Tom Fitton
This new information from the government shows that the serious safety concerns about the use of Gardasil have been well-founded. Public health officials should stop pushing Gardasil on children.
What was the information that prompted such a response?
The National Vaccine Injury Compensation Program (VICP) has awarded $5,877,710 dollars to 49 victims in claims made against the highly controversial HPV (human papillomavirus) vaccines. To date 200 claims have been filed with VICP, with barely half adjudicated. 
Not to appear to be concentrating on only one HPV vaccine, for the record, here is the vaccine package insert for GlaxoSmithKline’s Cervarix® HPV Vaccine, which includes only two HPV strains, 16 and 18. However, according to the vaccine’s package insert:
Each dose may also contain residual amounts of insect cell and viral protein (less than 40 ng) and bacterial cell protein (less than 150 ng) from the manufacturing process [Pg. 12]
And, 0.5 mg of aluminum hydroxide.
As I’m writing this article, breaking financial news reports indicate that Merck and Company, the makers of Gardasil®, “announced positive phase 3 results for its next generation HPV vaccine V503…” , which is to include 9 strains. The estimated annual sales for that new vaccine could amount to over $1 Billion a year.
Not to be outdone, GlaxoSmithKline is looking forward to being able to reduce its HPV vaccine Cervarix® protocol from 3 doses down to one dose and trials are in progress. 
What will the upcoming innovations in HPV vaccines portend for young boys and girls health status as more multi-valent vaccines are mandated for children who, in many cases, will be entering puberty – an emotional, hormonally vulnerable, and physiologically developmental phase of their lives?
Shortly before submitting this article for publication, I received an email from Norma at SaneVax sharing with me their latest blog about what’s going on in Japan regarding the movement there to legally ban both HPV vaccines due to serious adverse reactions and events happening to Japanese girls after inoculation. You may want to read HPV Vaccines Exposed: Subterfuge in a Syringe.
 Frompovich, Catherine J. Vaccination Voodoo, What YOU Don’t Know About Vaccines, p. 129
Catherine J Frompovich (website) is a retired natural nutritionist who earned advanced degrees in Nutrition and Holistic Health Sciences, Certification in Orthomolecular Theory and Practice plus Paralegal Studies. Her work has been published in national and airline magazines since the early 1980s. Catherine authored numerous books on health issues along with co-authoring papers and monographs with physicians, nurses, and holistic healthcare professionals. She has been a consumer healthcare researcher 35 years and counting.
Catherine’s latest book, published October 4, 2013, is Vaccination Voodoo, What YOU Don’t Know About Vaccines, available on Amazon.com.
Her 2012 book A Cancer Answer, Holistic BREAST Cancer Management, A Guide to Effective & Non-Toxic Treatments, is available on Amazon.com and as a Kindle eBook.
Two of Catherine’s more recent books on Amazon.com are Our Chemical Lives And The Hijacking Of Our DNA, A Probe Into What’s Probably Making Us Sick (2009) and Lord, How Can I Make It Through Grieving My Loss, An Inspirational Guide Through the Grieving Process (2008).